Clinical results of bioresorbable drug-eluting scaffolds in short and long coronary artery lesions using the PSP technique
BMC Cardiovascular Disorders Jan 24, 2019
Reichart C, et al. - Researchers compared patients with short (< 20 mm) and long (≥20 mm) coronary artery lesions in terms of long-term outcome up to 36 months after implantation of bioresorbable vascular scaffolds (BVS) with the PSP-technique (predilation, proper sizing, and postdilation). They conducted this prospective study with 326 patients who had 424 lesions. Patients underwent percutaneous coronary intervention with the Absorb BVS. Outcomes revealed significantly higher rates of device oriented composite endpoint (defined as cardiac death, myocardial infarction not clearly related to a non-target vessel and target lesion revascularization) in long lesions vs short ones when the bioresorbable scaffold Absorb was implanted with the PSP technique.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries